search
Back to results

The Effect of Perioperative Cardiac Output-guided GDT on Oxygen Delivery, Consumption, and Microcirculatory Perfusion (CUSTOM)

Primary Purpose

Caridac Output-guided Goal-directed Hemodynamic Therapy, Oxygen Delivery, Oxygen Consumption

Status
Completed
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
Treatment algorithms targeting cardiac output
Sponsored by
Universitätsklinikum Hamburg-Eppendorf
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Caridac Output-guided Goal-directed Hemodynamic Therapy focused on measuring non-cardiac surgery, oxygen consumption, oxygen delivery, microcirculatory perfusion, goal-directed hemodynamic therapy

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Adult patients (≥18 years) having elective major abdominal surgery with general anesthesia
  • Expected duration of surgery at least 120 minutes
  • Planned postoperative monitoring in intensive care unit

Exclusion Criteria:

  • Emergency surgery
  • Age <18 years
  • Body weight <50 kg
  • Pregnancy
  • Atrial fibrillation
  • Planned patient positioning in other position than supine position
  • Surgery within the last 30 days
  • Inaccessibility of the head during surgery
  • Peripheral artery disease stage ≥IIb
  • Chronic vasculitis
  • Supraglottic airway management
  • Enterostomy repair surgery

Sites / Locations

  • University Medical Center Hamburg-Eppendorf

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Active Comparator

Active Comparator

No Intervention

Arm Label

Cardiac output maximization group

Cardiac output personalization group

Routine management group

Arm Description

Patients will be treated according to a goal-directed therapy protocol aiming at a cardiac output maximization. Detailed protocol adapted from Edwards, M.R., et al., Optimisation of Perioperative Cardiovascular Management to Improve Surgical Outcome II (OPTIMISE II) trial: study protocol for a multicentre international trial of cardiac output-guided fluid therapy with low-dose inotrope infusion compared with usual care in patients undergoing major elective gastrointestinal surgery. BMJ Open, 2019. 9(1): p. e023455.

Patients will be treated according to a goal-directed therapy protocol aiming at a personalized cardiac output goal determined with preoperative cardiac output assessment. Detailed protocol adapted from Nicklas, J.Y., et al., Personalised haemodynamic management targeting baseline cardiac index in high-risk patients undergoing major abdominal surgery: a randomised single-centre clinical trial. Br J Anaesth, 2020. 125(2): p. 122-132.

Patients will be treated according to routine hemodynamic management.

Outcomes

Primary Outcome Measures

Perioperative changes in oxygen delivery
assessed via blood gas analysis
Perioperative changes in oxygen consumption
assessed via indirect calorimetry

Secondary Outcome Measures

Perioperative changes of microcirculation
assessed via Incident Darkfield technology
Perioperative changes in cardiac output
assessed via pulse wave analysis

Full Information

First Posted
August 29, 2021
Last Updated
June 29, 2022
Sponsor
Universitätsklinikum Hamburg-Eppendorf
search

1. Study Identification

Unique Protocol Identification Number
NCT05090254
Brief Title
The Effect of Perioperative Cardiac Output-guided GDT on Oxygen Delivery, Consumption, and Microcirculatory Perfusion
Acronym
CUSTOM
Official Title
The Effect of Perioperative Cardiac Output-guided Goal-directed Hemodynamic Therapy (GDT) on Perioperative Oxygen Delivery, Consumption, and Microcirculatory Perfusion in Comparison to Routine Hemodynamic Management
Study Type
Interventional

2. Study Status

Record Verification Date
June 2022
Overall Recruitment Status
Completed
Study Start Date
August 1, 2021 (Actual)
Primary Completion Date
May 31, 2022 (Actual)
Study Completion Date
May 31, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Universitätsklinikum Hamburg-Eppendorf

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Perioperative cardiac output-guided goal-directed therapy (GDT) triggers fluid, vasopressor, and inotrope administration assuming that optimizing cardiac output (i.e., global blood flow) ensures adequate oxygen delivery and microcirculatory perfusion - that are usually not directly monitored during goal-directed therapy. There is increasing evidence that perioperative cardiac output-guided goal-directed therapy may reduce postoperative complications compared to routine hemodynamic management in high-risk patients having major surgery. The effect of cardiac output-guided goal-directed therapy algorithms on perioperative oxygen delivery and consumption as well as microcirculatory perfusion, however, is unknown. The investigators aim to investigate the effect of using different cardiac output-guided goal-directed therapy algorithms on perioperative oxygen delivery and consumption as well as sublingual microcirculatory perfusion compared to routine perioperative hemodynamic management in patients having major abdominal surgery with general anesthesia.
Detailed Description
Perioperative cardiac output-guided goal-directed therapy (GDT) triggers fluid, vasopressor, and inotrope administration assuming that optimizing cardiac output (i.e., global blood flow) ensures adequate oxygen delivery and microcirculatory perfusion - that are usually not directly monitored during goal-directed therapy. There is increasing evidence that perioperative cardiac output-guided goal-directed therapy may reduce postoperative complications compared to routine hemodynamic management in high-risk patients having major surgery. The effect of cardiac output-guided goal-directed therapy algorithms on perioperative oxygen delivery and consumption as well as microcirculatory perfusion, however, is unknown. With technological advancements a distinct monitoring of oxygen delivery and consumption as well as microcirculatory perfusion in the perioperative period has become possible. Using new technologies, a detailed understanding of the effect of cardiac output-guided goal-directed therapy on perioperative oxygen delivery and consumption as well as microcirculatory perfusion is of vital importance to further develop and improve perioperative hemodynamic treatment strategies. In this pilot randomized-controlled trial, the investigators therefore aim to investigate the effect of using different cardiac output-guided goal-directed therapy algorithms on perioperative oxygen delivery and consumption as well as sublingual microcirculatory perfusion compared to routine perioperative hemodynamic management in patients having major abdominal surgery with general anesthesia.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Caridac Output-guided Goal-directed Hemodynamic Therapy, Oxygen Delivery, Oxygen Consumption, Microcirculatory Perfusion, Major Non-cardiac Surgery, Postoperative Acute Kidney Injury, Postoperative Acute Myocardial Injury
Keywords
non-cardiac surgery, oxygen consumption, oxygen delivery, microcirculatory perfusion, goal-directed hemodynamic therapy

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
78 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Cardiac output maximization group
Arm Type
Active Comparator
Arm Description
Patients will be treated according to a goal-directed therapy protocol aiming at a cardiac output maximization. Detailed protocol adapted from Edwards, M.R., et al., Optimisation of Perioperative Cardiovascular Management to Improve Surgical Outcome II (OPTIMISE II) trial: study protocol for a multicentre international trial of cardiac output-guided fluid therapy with low-dose inotrope infusion compared with usual care in patients undergoing major elective gastrointestinal surgery. BMJ Open, 2019. 9(1): p. e023455.
Arm Title
Cardiac output personalization group
Arm Type
Active Comparator
Arm Description
Patients will be treated according to a goal-directed therapy protocol aiming at a personalized cardiac output goal determined with preoperative cardiac output assessment. Detailed protocol adapted from Nicklas, J.Y., et al., Personalised haemodynamic management targeting baseline cardiac index in high-risk patients undergoing major abdominal surgery: a randomised single-centre clinical trial. Br J Anaesth, 2020. 125(2): p. 122-132.
Arm Title
Routine management group
Arm Type
No Intervention
Arm Description
Patients will be treated according to routine hemodynamic management.
Intervention Type
Other
Intervention Name(s)
Treatment algorithms targeting cardiac output
Intervention Description
Treatment algorithms targeting maximization or personalization of cardiac output
Primary Outcome Measure Information:
Title
Perioperative changes in oxygen delivery
Description
assessed via blood gas analysis
Time Frame
after induction of general anesthesia, during the last 30 minutes of surgery, within 6 hours after surgery, day 1, 2, 3 after surgery
Title
Perioperative changes in oxygen consumption
Description
assessed via indirect calorimetry
Time Frame
baseline awake, after induction of general anesthesia, during the last 30 minutes of surgery, within 6 hours after surgery, day 1, 2, 3 after surgery
Secondary Outcome Measure Information:
Title
Perioperative changes of microcirculation
Description
assessed via Incident Darkfield technology
Time Frame
baseline awake, after induction of general anesthesia, during the last 30 minutes of surgery, within 6 hours after surgery, day 1, 2, 3 after surgery
Title
Perioperative changes in cardiac output
Description
assessed via pulse wave analysis
Time Frame
baseline awake, after induction of general anesthesia, during the last 30 minutes of surgery, within 6 hours after surgery, day 1, 2, 3 after surgery
Other Pre-specified Outcome Measures:
Title
Incidence of postoperative myocardial injury
Description
assessed via blood samples
Time Frame
baseline awake, within 6 hours after surgery, and on day 1, 2, and 3 after surgery
Title
Incidence of acute kidney injury
Description
assessed via blood samples
Time Frame
baseline awake, within 6 hours after surgery, and on day 1, 2, and 3 after surgery
Title
Perioperative changes in urethral perfusion index
Description
assessed via urethral photoplethysmography
Time Frame
after induction of general anesthesia, during the last 30 minutes of surgery, within 6 hours after surgery, day 1, 2, 3 after surgery

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Adult patients (≥18 years) having elective major abdominal surgery with general anesthesia Expected duration of surgery at least 120 minutes Planned postoperative monitoring in intensive care unit Exclusion Criteria: Emergency surgery Age <18 years Body weight <50 kg Pregnancy Atrial fibrillation Planned patient positioning in other position than supine position Surgery within the last 30 days Inaccessibility of the head during surgery Peripheral artery disease stage ≥IIb Chronic vasculitis Supraglottic airway management Enterostomy repair surgery
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Bernd Saugel, Prof., MD
Organizational Affiliation
The University Medical Center Hamburg-Eppendorf
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Medical Center Hamburg-Eppendorf
City
Hamburg
ZIP/Postal Code
20246
Country
Germany

12. IPD Sharing Statement

Learn more about this trial

The Effect of Perioperative Cardiac Output-guided GDT on Oxygen Delivery, Consumption, and Microcirculatory Perfusion

We'll reach out to this number within 24 hrs